Clinical Trial Update: Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enzastaurin with 5-FU/LV and bevacizumab as maintenance after first-line therapy in metastatic colorectal cancer has completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil/Leucovorin (5-FU/leucovorin)
• Bevacizumab (bevacizumab)
• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-07-21